We are live on
!
Find out more
SC
SMA Capital Portfolio holdings
AUM
$238M
This Fund
S&P 500
This Quarter
Est. Return
+14.62%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$238M
AUM Growth
+$6.45M
(+2.8%)
Cap. Flow
-$11.8M
Cap. Flow
% of AUM
-4.96%
Top 10 Holdings %
Top 10 Hldgs %
37.07%
Holding
184
New
89
Increased
22
Reduced
10
Closed
63
Avg Time Held
0.3
quarters
Top 10 Avg Time Held
0.9
quarters
Top 20 Avg Time Held
0.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$7.92M |
| 2 |
ITT
ITT
|
+$7.28M |
| 3 |
Packaging Corp of America
PKG
|
+$7.02M |
| 4 |
JB Hunt Transport Services
JBHT
|
+$6.42M |
| 5 |
Teledyne Technologies
TDY
|
+$6.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$10.3M |
| 2 |
Eaton
ETN
|
+$10.1M |
| 3 |
Caterpillar
CAT
|
+$9.48M |
| 4 |
Ferguson
FERG
|
+$8.32M |
| 5 |
Linde
LIN
|
+$7.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 55.56% |
| 2 | Consumer Discretionary | 17.53% |
| 3 | Technology | 8.66% |
| 4 | Materials | 6.15% |
| 5 | Consumer Staples | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Jazz Pharmaceuticals
JAZZ
$14.2B
| – | – |
-117
| Closed | -$22.1K | – |
|
152
Kirby Corp
KEX
$7.19B
| – | – |
-36,460
| Closed | -$4.84M | – |
|
|
153
Linde
LIN
$223B
| – | – |
-15,161
| Closed | -$7.49M | – |
|
154
Eli Lilly
LLY
$1.05T
| – | – |
-21
| Closed | -$19.3K | – |
|
155
Lockheed Martin
LMT
$118B
| – | – |
-11,819
| Closed | -$7.14M | – |
|
156
Liquidia Corp
LQDA
$2.45B
| – | – |
-195
| Closed | -$7.36K | – |
|
157
Martin Marietta Materials
MLM
$34B
| – | – |
-5,126
| Closed | -$3.02M | – |
|
158
Novanta
NOVT
$5.34B
| – | – |
-30,563
| Closed | -$3.61M | – |
|
159
Natera
NTRA
$57.8B
| – | – |
-112
| Closed | -$22.4K | – |
|
160
Nucor
NUE
$56.8B
| – | – |
-19,137
| Closed | -$3.24M | – |
|
161
Phibro Animal Health
PAHC
$1.56B
| – | – |
-111
| Closed | -$6.14K | – |
|
162
Insulet
PODD
$9.38B
| – | – |
-92
| Closed | -$19.3K | – |
|
163
Repligen
RGEN
$11B
| – | – |
-48
| Closed | -$5.66K | – |
|
164
Royalty Pharma
RPRX
$25.3B
| – | – |
-481
| Closed | -$23.1K | – |
|
|
SLNO
165
DELISTED
Soleno Therapeutics
SLNO
| – | – |
-153
| Closed | -$5.12K | – |
|
|
TERN
166
DELISTED
Terns Pharmaceuticals
TERN
| – | – |
-143
| Closed | -$7.54K | – |
|
167
Timken Company
TKR
$8.05B
| – | – |
-66,150
| Closed | -$6.65M | – |
|
168
Travere Therapeutics
TVTX
$4.91B
| – | – |
-205
| Closed | -$6.09K | – |
|
169
UnitedHealth
UNH
$340B
| – | – |
-77
| Closed | -$20.8K | – |
|
170
Viridian Therapeutics
VRDN
$2.11B
| – | – |
-203
| Closed | -$3.97K | – |
|
171
Wabtec
WAB
$48.2B
| – | – |
-22,700
| Closed | -$5.67M | – |
|
172
Waters Corp
WAT
$42.6B
| – | – |
-73
| Closed | -$21.7K | – |
|
173
Waste Management
WM
$83.5B
| – | – |
-21,947
| Closed | -$5.04M | – |
|
174
Watts Water Technologies
WTS
$11.8B
| – | – |
-10,922
| Closed | -$3.17M | – |
|
175
Wave Life Sciences
WVE
$682M
| – | – |
-433
| Closed | -$3.14K | – |
|
Similar funds
RMC
PFA
TCM
SAM
CWM
CNBOF
NSB
CCA
SMA Capital's Q2 2026 Portfolio in Review
As of Q2 2026, SMA Capital held 184 positions worth $238M, up 2.8% from $232M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
SMA Capital withdrew a net $11.8M in Q2 2026, closing 63 positions and reducing 10 holdings. Its most notable exit was Boeing, an estimated $10.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 56% of assets, down from 79% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, SMA Capital opened a new position in CRH worth $7.7M.
- SMA Capital's largest Q2 2026 buy was CRH: 72,000 shares worth $7.7M.
- SMA Capital added most to Ametek in Q2 2026, an estimated $2.33M increase.
- SMA Capital's biggest Q2 2026 reduction was Applied Industrial Technologies, cutting an estimated $5.83M.
- SMA Capital fully exited Boeing in Q2 2026, selling an estimated $10.3M.
- SMA Capital's ten largest holdings make up 37% of its $238M portfolio in Q2 2026.
- SMA Capital opened 89 new positions and closed 63 in Q2 2026.
- SMA Capital's portfolio value rose 2.8% quarter-over-quarter to $238M.
Based on SMA Capital's 13F filing for Q2 2026, filed 14 Aug 2026.